Omics Services for Cardiovascular Diseases

In recent years, omics is a rapidly evolving bioanalytical technology that is a powerful research tool for studying the pathogenesis of cardiovascular disease. Ace Therapeutics provides multi-omics services to aggressively advance the study of cardiovascular disease pathogenesis and the development of diagnostic and therapeutic strategies.

Application of Omics Technologies in Cardiovascular Disease Research

In the last decade, omics technologies, including genomics, transcriptomics, proteomics and metabolomics, have developed rapidly and become an integrated science and technology for studying different levels and dimensions of biology. Undoubtedly, in the field of cardiovascular disease research, omics technology has gradually become an important tool for studying the pathogenesis and pharmacological mechanisms of various cardiovascular diseases, and has been widely used in the discovery of cardiovascular biomarkers and signaling pathway research.

Fig. 1 Downstream effects of microbe-derived metabolites and their roles in CVDs. (Xu J, and Yang Y, 2021)

Ace Therapeutics strives to provide cardiovascular disease researchers with comprehensive and high-quality muti-omics solutions, and is committed to helping you solve difficulties encountered in cardiovascular disease research.

Ace Therapeutics is a contract research organization specializing in cardiovascular disease research. We strive to provide high-quality omics research solutions for researchers to promote new breakthroughs and advances in research into cardiovascular disease. If you are interested in our omics services for cardiovascular diseases, please do not hesitate to contact us.

1. Xu, J.; Yang, Y. Gut microbiome and its meta-omics perspectives: profound implications for cardiovascular diseases. Gut Microbes. 2021, 13(1): 1936379.